Vida Ventures Advisors, LLC
Q4 2024 13F Holdings
- Locationboston, MA
- Num holdings
6
- Value ($000)
$146,329
- Date Filed01/21/2025
- Form type13F-HR
- CIK0001831423
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
CNTA Centessa Pharmaceuticals plc | ORDINARY SHARES | 152309100 | $65.86M | 45 % | 3,931,818 | ||
TECX Tectonic Therapeutics, Inc. | COMMON STOCK | 878972108 | $47.49M | 33 % | 1,028,674 | ||
KYTX Kyverna Therapeutics, Inc. | COMMON STOCK | 501976104 | $16.92M | 12 % | 4,523,924 | ||
DYN Dyne Therapeutics, Inc. | COMMON STOCK | 26818M108 | $9.60M | 7 % | 407,499 | ||
ALLO Allogene Therapeutics, Inc. | COMMON STOCK | 019770106 | $3.83M | 3 % | 1,798,163 | ||
KRON Kronos Bio, Inc. | COMMON STOCK | 50107A104 | $2.63M | 2 % | 2,765,314 |
Rows Per Page
1 - 6 of 610
- 10
- 50
- 100